Skip to main contentSkip to navigation
Sirius Investors
AnPac Bio-Medical Science Co., Ltd.

AnPac Bio-Medical Science Co., Ltd.

ANPC
NASDAQHealthcare

Revenue Analysis - ANPC

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

ANPC Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Cancer screening and detection tests

0.0% of total revenue

$3.7M

Technology services

0.0% of total revenue

$1.2M

Retail revenue

0.0% of total revenue

$207.0K

Physical checkup packages

0.0% of total revenue

$31.0K

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 2 records)

Date
Cancer Screening And Detection Test
Cancer screening and detection tests
Physical Checkup Package
Physical checkup packages
Retail revenue
Technology services
6/30/2022$0$3.7M$0$31.0K$207.0K$1.2M
6/30/2021$9.2M$0$16.0K$0$0$0

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Stable Segments
Cancer screening and detection tests0.0%
Technology services0.0%
Retail revenue0.0%

Earnings Reports

Want to see how ANPC's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports